Innovation Grand Rounds by Derek O’Hagan, GSK Vaccines
- Event Type
- Seminar/Symposium
- Sponsor
- Carle Illinois College of Medicine
- Virtual
- Join online
- Date
- Aug 13, 2021 12:00 - 1:30 pm
- Speaker
- Derek O’Hagan, Senior Advisor in R&D at GSK Vaccines
- Contact
- Angie Ellis
- amellis@illinois.edu
- Phone
- 217-300-1910
- Views
- 204
- Originating Calendar
- Carle Illinois College of Medicine General Events
Designing the Next Generation of Vaccines
by Derek O’Hagan, BPharm, MRPharmS, PhD
Carle Illinois College of Medicine
Innovation Grand Rounds
Friday, August 13, 2021
noon – 1:00 p.m. Presentation by Derek O’Hagan
1:00 – 1:30 p.m. Reflection & Dialogue
Zoom Call-in: go.illinois.edu/innovationgrandrounds
Abstract: The licensed vaccines are safe and effective and offer protection against a broad range of infectious diseases. However, the recent pandemic has highlighted some limitations, whilst also offering opportunities for new technologies to be advanced to meet the ongoing challenge. I will cover the science behind some of the newer technologies, including new adjuvant systems and RNA vaccines, and compare them with the more established approaches to vaccine development. I will highlight both the advantages and limitations, while addressing if the newer approaches have put us in a better place to allow us to meet future challenges.
Derek O’Hagan, BPharm, MRPharmS, PhD is currently a Senior Advisor in R&D in GSK Vaccines, since 2018, and a GSK Fellow, since 2019. Prior to this I was the Global Head of Discovery Support and New Technology in GSK Vaccines. Until 2015, I was the Global Head of Vaccine Chemistry and Formulation Research for Novartis Vaccines. I have extensive experience on Vaccine Adjuvants, including participation in the R&D of those included in licensed products and I was part of the Team that established the program on Self Amplifying RNA vaccines (SAM) in Novartis, Cambridge, which is now active in GSK. I served on the Board of Scientific Advisors for the Controlled Release Society and I am a Fellow of the American Association of Pharmaceutical Scientists. I was awarded the Conference Science medal of the Royal Pharmaceutical Society of Great Britain in 1997, and the Young Investigator Research Achievement Award of the Controlled Release Society in 1999. I was also named as the ‘most inventive scientist’ in Chiron in 2004 and was the lead author on the most cited paper in ‘Vaccine’ 2008-10.